Skip to main content
Biotalys logo

Biotalys — Investor Relations & Filings

Ticker · BTLS ISIN · BE0974386188 LEI · 69940040QC7E3C0G3X07 BR Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2025-01-27 Declaration of Voting R…
Country BE Belgium
Listing BR BTLS

About Biotalys

https://www.biotalys.com/

Biotalys is an agricultural technology (AgTech) company developing a new generation of protein-based biocontrol solutions for crop and food protection. The company utilizes its proprietary technology platform to create a pipeline of effective and safe products with novel modes of action. These solutions are designed to control key crop pests and diseases across the food value chain, contributing to a more sustainable and safer food supply.

Recent filings

Filing Released Lang Actions
Biotalys Press Release Regulated Information_27 January 2025.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Press release - regulated information" and specifically announces "Information on the total number of voting rights and shares." It explicitly references the Belgian Act of 2 May 2007 regarding the disclosure of major shareholdings and details the total number of securities carrying voting rights, including warrants and share units. This content directly relates to changes in significant share ownership thresholds and the total denominator for voting rights, which aligns perfectly with the definition of a Major Shareholding Notification (MRQ). Although it is a press release, the core subject matter is the calculation and disclosure of voting rights/share capital, which is a specific type of major holding disclosure.
2025-01-27 English
Biotalys Persbericht Gereglementeerde Informatie_27 januari 2025.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Persbericht – gereglementeerde informatie" (Press Release – regulated information) and specifically concerns "Informatie betreffende het totale aantal stemrechten en aandelen" (Information concerning the total number of voting rights and shares). It details the total number of voting rights (37,470,062) and outstanding capital, referencing the Belgian law on disclosure of major shareholdings. This type of mandatory disclosure regarding the total number of shares and voting rights, often triggered by changes or as a periodic update required by local regulation (like Article 15 of the Belgian Law mentioned), fits best under the category dealing with significant share ownership notifications or general regulatory updates. Since it explicitly details the total number of voting rights (the denominator for major shareholding calculations), it aligns closely with 'Major Shareholding Notification' (MRQ), which covers changes in significant share ownership levels, or potentially a general 'Regulatory Filing' (RNS). Given the focus on the total number of voting rights (the denominator), MRQ is the most specific fit, as these figures are crucial for determining when a major shareholder must notify the company/regulator.
2025-01-27 Dutch
Biotalys Press Release Regulatory Update_14 January 2025.pdf
Legal Proceedings Report Classification · 100% confidence The document is a press release issued by Biotalys regarding the regulatory review status of its product, EVOCA, in the EU and the US. It provides updates on regulatory milestones (CTGB recommendation, EPA/CDPR review status) and is clearly labeled as a 'Press release – inside information'. It does not constitute a full financial report, audit, or proxy statement, but rather a corporate announcement regarding operational/regulatory progress. As it does not fit into more specific categories like M&A or share issuance, it falls under the general regulatory announcement category.
2025-01-14 English
Persbericht Biotalys Regulatory Update_14 januari 2025.pdf
Regulatory Filings Classification · 100% confidence The document is a press release from Biotalys providing an update on the regulatory review process for their product 'EVOCA' in the EU and the US. It details the recommendation from the Dutch regulatory body (CTGB) and the status of the EPA review. This document does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a simple report publication announcement (RPA) as it provides substantive news regarding company operations and regulatory milestones. Therefore, it is classified as a general regulatory announcement under the RNS category.
2025-01-14 Dutch
Biotalys Press Release Regulatory Update_14 January 2025.pdf
Legal Proceedings Report Classification · 99% confidence The document is explicitly titled "Press release – inside information" and provides an update on the regulatory review process for a product (EVOCA) in the EU and US. It details milestones like receiving a Draft Assessment Report from the Dutch regulatory authority (CTGB) and mentions ongoing review by the EPA. This type of announcement, which communicates material, non-public information regarding regulatory progress, fits best under a general regulatory announcement category. Since it is not a full financial report (10-K, IR), a specific earnings release (ER), or a formal shareholder vote result (DVA), the most appropriate classification is Regulatory Filings (RNS), which serves as a general category for significant, non-standard regulatory updates that are not covered by other specific codes. The length (6827 chars) is substantial, but the content is purely informational/update-based rather than being the full report itself.
2025-01-14 English
Persbericht Biotalys Regulatory Update_14 januari 2025.pdf
Legal Proceedings Report Classification · 99% confidence The document is titled "Persbericht – voorkennis" (Press Release – inside information) and announces an update regarding the regulatory assessment of a product (EVOCA) in the EU and the US. It details progress with the Dutch regulator (CTGB) and mentions ongoing review by the US EPA. This type of announcement, providing key operational and regulatory updates outside of scheduled financial reports, is characteristic of a general regulatory announcement or press release. Since it is not a full financial report (10-K, IR), an earnings release (ER), or a specific shareholder vote result (DVA), the most appropriate general category for a significant, non-financial regulatory update that doesn't fit elsewhere is Regulatory Filings (RNS). The document length (7602 chars) is substantial enough that it is the primary communication, not just a brief announcement of an attached report (which would suggest RPA).
2025-01-14 Dutch

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.